Asia-Pacific Fluorescent Immunoassay Market Forecast to 2028

Report Code : BMIRE00025659 | Region : Asia Pacific | Industry : Biotechnology | Published Date : 10/Aug/2022
Asia-Pacific Fluorescent Immunoassay Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (ELISA, Rapid Lateral Flow Immunoassay, and Others), Application (Infectious Diseases, Oncology, Cardiovascular Diseases, and Others), and End User (Hospitals & Clinics, Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others)

The APAC fluorescent immunoassay market is expected to grow from US$ 503.91 million in 2021 to US$ 811.10 million by 2028; it is estimated to grow at a CAGR of 7.0% from 2021 to 2028.

Fluorescent dyes or fluorophores have been widely used as probes (for physical and structural parameters), indicators (e.g., for molecular concentrations), or labels/tracers (e.g., for visualization and localization of biomolecules) in various bioassays. Therefore, the development of fluorescent dyes, accompanied by appropriate devices and their applications, has significantly impacted the healthcare sector. New technologies, materials, and devices have been developed to detect and utilize fluorescence signals in biological samples efficiently. The need for sensitive and inexpensive diagnostic tools has led to new strategies to enhance the fluorescence signal of diagnostic assays, including improving the surface immobilization of biomolecules, increasing the density of fluorescent labels per binding event, and improving the optical properties of fluorescent reporters. One way to enhance fluorescence performance is to develop fluorescent dyes with improved brightness, photostability, quantum yield, and Stokes shift. Fluorescent labels have also been used to create homogeneous immunoassays by various techniques. Fluorescein isothiocyanate (FITC) is an organic fluorescent dye and probably one of the most used in immunofluorescence and flow cytometry. It can be coupled to various antibodies using its reactive isothiocyanate group, which binds to amino, sulfhydryl, imidazolyl, tyrosyl, or carbonyl groups of proteins. FITC was one of the first dyes used for fluorescence microscopy and served as a precursor to other fluorescent dyes. Its fluorescence activity is due to its extensive conjugated aromatic electron system, which is excited by the blue light spectrum. Therefore, due to the increase in the development of fluorescent dyes and instruments, the fluorescent immunoassays market is expected to grow in the coming years.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC fluorescent immunoassay market at a notable CAGR during the forecast period.

APAC Fluorescent Immunoassay Market Revenue and Forecast to 2028 (US$ Million)

APAC Fluorescent Immunoassay Market Segmentation

The APAC fluorescent immunoassay market is segmented into product type, application, end user, and country. Based on product type, the market is segmented into ELISA, rapid lateral flow immunoassay, and others. The ELISA segment dominated the market in 2021 and is expected to be fastest growing during forecast period. Based on application, the market is segmented into infectious diseases, oncology, cardiovascular diseases, and others. The infectious disease segment dominated the market in 2021 and is expected to be fastest growing during forecast period. Based on end user, the market is segmented into hospitals & clinics, diagnostic centers, pharmaceutical & biotechnology companies, academic & research institutes, and others. The hospitals and clinics segment dominated the market in 2021 and is expected to be fastest growing during forecast period. Based on country, the APAC fluorescent immunoassay market is segmented into China, Japan, India, South Korea, Australia, and the Rest of APAC.

Abbott, BD, bioMerieux SA, Danaher, F. Hoffmann-La Roche Ltd., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific Inc. are among the leading companies operating in the APAC fluorescent immunoassay market.

The List of Companies - Asia-Pacific Fluorescent Immunoassay Market

● Abbott

● BD

● bioMerieux SA

● Danaher

● F. Hoffmann-La Roche Ltd.

● Ortho Clinical Diagnostics Holdings plc

● Quidel Corporation

● Siemens AG

● Sysmex Corporation

● Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Fluorescent Immunoassay Market – By Product Type

1.3.2 APAC Fluorescent Immunoassay Market – By Application

1.3.3 APAC Fluorescent Immunoassay Market – By End User

1.3.4 APAC Fluorescent Immunoassay Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Fluorescent Immunoassay Market – Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Expert Opinions

5. APAC Fluorescent Immunoassay Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Prevalence of Chronic Diseases

5.1.2 Increasing Demand for Cell Therapies

5.2 Market Restraints

5.2.1 Disadvantages of Fluorescent Immunoassays

5.3 Market Opportunities

5.3.1 Extensive Usage in Cancer Diagnostics

5.4 Future Trends

5.4.1 Increase in Development of Fluorescent Dyes and Instruments

5.5 Impact Analysis

6. Fluorescent Immunoassay Market – APAC Analysis

6.1 APAC Fluorescent Immunoassay Marker Revenue Forecast and Analysis

7. APAC Fluorescent Immunoassay Market Analysis – By Product Type

7.1 Overview

7.2 APAC Fluorescent Immunoassay Market Share by Product Type - 2021 & 2028 (%)

7.3 ELISA

7.3.1 Overview

7.3.2 ELISA: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

7.4 Rapid Lateral Flow Immunoassay

7.4.1 Overview

7.4.2 Rapid Lateral Flow Immunoassay: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

7.5 Others

7.5.1 Overview

7.5.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

8. APAC Fluorescent Immunoassay Market Analysis – By Application

8.1 Overview

8.2 APAC Fluorescent Immunoassay Market Share by Application - 2021 & 2028 (%)

8.3 Infectious Diseases

8.3.1 Overview

8.3.2 Infectious Diseases: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

8.4 Oncology

8.4.1 Overview

8.4.2 Oncology: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

8.5 Cardiovascular Disease

8.5.1 Overview

8.5.2 Cardiovascular Disease: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9. APAC Fluorescent Immunoassay Market Analysis – By End User

9.1 Overview

9.2 APAC Fluorescent Immunoassay Market Share by End User - 2021 & 2028 (%)

9.3 Hospitals & Clinics

9.3.1 Overview

9.3.2 Hospitals & Clinics: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9.4 Diagnostic Centers

9.4.1 Overview

9.4.2 Diagnostic Centers: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9.5 Pharmaceutical & Biotechnology Companies

9.5.1 Overview

9.5.2 Pharmaceutical & Biotechnology Companies: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9.6 Academic & Research Institutes

9.6.1 Overview

9.6.2 Academic & Research Institutes: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)

10. APAC Fluorescent Immunoassay Market Analysis – By Country

10.1 Overview

10.1.1 Asia Pacific: Fluorescent Immunoassay Market, by Country, 2021 & 2028 (%)

10.1.1.1 China: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.1 China: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.2 China Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3 China: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.4 China: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.2 Japan: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.1 Japan: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.2 Japan: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3 Japan: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.4 Japan: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.3 India: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1 India: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.2 India: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3 India: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.4 India: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.4 South Korea: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.1 South Korea: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.2 South Korea: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3 South Korea: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.4 South Korea: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.5 Australia: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.1 Australia: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.2 Australia: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.3 Australia: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.4 Australia: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.6 Rest of Asia Pacific: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.1 Rest of Asia Pacific: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.2 Rest of Asia Pacific: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3 Rest of Asia Pacific: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.4 Rest of Asia Pacific: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)

11. Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Thermo Fisher Scientific Inc.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Abbott

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 BD

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Danaher

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 bioMerieux SA

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Sysmex Corporation

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Siemens AG

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Ortho Clinical Diagnostics Holdings plc

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Quidel Corporation

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About the Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1.             APAC Fluorescent Immunoassay Market –Revenue and Forecast to 2028 (USD Million)

Table 2.             China: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

Table 3.             China: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             China: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 5.             Japan: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

Table 6.             Japan: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7.             Japan: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 8.             India: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

Table 9.             India: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 10.          India: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 11.          South Korea: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

Table 12.          South Korea: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 13.          South Korea: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 14.          Australia: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

Table 15.          Australia: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16.          Australia: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17.          Rest of Asia Pacific: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

Table 18.          Rest of Asia Pacific: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19.          Rest of Asia Pacific: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028(USD Million)

Table 20.          Organic Developments

Table 21.          Inorganic Developments

Table 22.          Glossary of Terms

The List of Companies - Asia-Pacific Fluorescent Immunoassay Market

● Abbott

● BD

● bioMerieux SA

● Danaher

● F. Hoffmann-La Roche Ltd.

● Ortho Clinical Diagnostics Holdings plc

● Quidel Corporation

● Siemens AG

● Sysmex Corporation

● Thermo Fisher Scientific Inc.

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC fluorescent immunoassay market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the APAC fluorescent immunoassay market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the fluorescent immunoassay market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Asia-Pacific Fluorescent Immunoassay Market Forecast to 2028 )
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry